Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Late-Relapsing Hepatitis after Yellow Fever.
Rezende IM, Pereira LS, Fradico JRB, Pascoal Xavier MA, Alves PA, Campi-Azevedo AC, Speziali E, Dos Santos LZM, Albuquerque NS, Penido I, Santos TA, Bom APDA, da Silva AMV, Fernandes CB, Calzavara CE, Kroon EG, Martins-Filho OA, Teixeira-Carvalho A, Drumond BP. Rezende IM, et al. Among authors: fradico jrb. Viruses. 2020 Feb 17;12(2):222. doi: 10.3390/v12020222. Viruses. 2020. PMID: 32079143 Free PMC article.
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Fradico JRB, Souza-Lopes T, Reis LR, Freire LC, Costa-Pereira C, Mambrini JVM, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, de Castro TDM, Homma A, Romano APM, Domingues CM, Martins RM, Teixeira-Carvalho A, Martins-Filho OA. da Costa-Rocha IA, et al. Among authors: fradico jrb. Front Immunol. 2019 Jun 21;10:1211. doi: 10.3389/fimmu.2019.01211. eCollection 2019. Front Immunol. 2019. PMID: 31293563 Free PMC article. Clinical Trial.
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Fradico JRB, Souza-Lopes T, Reis LR, Freire LC, Costa-Pereira C, Mambrini JVM, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, de Castro TDM, Homma A, Romano APM, Domingues CM, Martins RM, Teixeira-Carvalho A, Martins-Filho OA. da Costa-Rocha IA, et al. Among authors: fradico jrb. Front Immunol. 2019 Oct 22;10:2433. doi: 10.3389/fimmu.2019.02433. eCollection 2019. Front Immunol. 2019. PMID: 31695694 Free PMC article.
CCL3, CCL5, IL-15, IL-1Ra and VEGF compose a reliable algorithm to discriminate classes of adverse events following 17DD-YF primary vaccination according to cause-specific definitions.
Fradico JRB, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JGA, Faria ES, Drumond BP, de Rezende IM, Almeida JF, da Silva RB, Gusmão JD, Arcoverde Medeiros EL, Rodrigues RCM, Ribeiro JGL, Pereira MA, Silva MVF, Rocha MLC, Adelino TER, de Melo Iani FC, Pereira GC, Fernandes EG, Auxiliadora-Martins M, Valim V, de Souza Gomes M, Amaral LR, Romano APM, Ramos DG, Carvalho SMD, Fantinato FFST, do Carmo Said RF, Teixeira-Carvalho A, Martins-Filho OA. Fradico JRB, et al. Vaccine. 2021 Jul 13;39(31):4359-4372. doi: 10.1016/j.vaccine.2021.05.101. Epub 2021 Jun 16. Vaccine. 2021. PMID: 34147295
Acute-Phase Levels of CXCL8 as Risk Factor for Chronic Arthralgia Following Chikungunya Virus Infection.
Jacob-Nascimento LC, Carvalho CX, Silva MMO, Kikuti M, Anjos RO, Fradico JRB, Campi-Azevedo AC, Tauro LB, Campos GS, Moreira PSDS, Portilho MM, Martins-Filho OA, Ribeiro GS, Reis MG. Jacob-Nascimento LC, et al. Among authors: fradico jrb. Front Immunol. 2021 Oct 1;12:744183. doi: 10.3389/fimmu.2021.744183. eCollection 2021. Front Immunol. 2021. PMID: 34659240 Free PMC article.
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients.
Fradico JRB, Campi-Azevedo AC, Speziali E, do Valle Antonelli LR, Peruhype-Magalhães V, de Rezende IM, Alves PA, Pascoal-Xavier MA, Pereira LS, Dutra MRT, Ramalho DB, Cenachi A, de Paula L, Santos TA, do Carmo Said RF, Calzavara-Silva CE, Coelho-Dos-Reis JGA, de Magalhães CR, Rabelo LLC, Valim V, Brito-de-Sousa JP, da Costa-Rocha IA, de Souza Gomes M, Amaral LR, de Lima SMB, Trindade GF, Santos RT, da Silva JFA, Monath T, LaBeaud AD, Drumond BP, Martins-Filho OA, Teixeira-Carvalho A; Yellow Fever Collaborative Group. Fradico JRB, et al. Clin Immunol. 2023 Jun;251:109321. doi: 10.1016/j.clim.2023.109321. Epub 2023 Apr 3. Clin Immunol. 2023. PMID: 37019421
Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil.
Gonçalves AP, Almeida LT, Rezende IMd, Fradico JRB, Pereira LS, Ramalho DB, Pascoal Xavier MA, Calzavara Silva CE, Monath TP, LaBeaud AD, Drumond BP, Campi-Azevedo AC, Martins-Filho OA, Teixeira-Carvalho A, Alves PA; Grupo de Estudos de Pesquisa e Resposta em Febre Amarela do Estado de Minas Gerais. Gonçalves AP, et al. Among authors: fradico jrb. Microbiol Spectr. 2024 May 2;12(5):e0370323. doi: 10.1128/spectrum.03703-23. Epub 2024 Mar 21. Microbiol Spectr. 2024. PMID: 38511952 Free PMC article.
13 results